Cameron Durrant - 31 Dec 2021 Form 4 Insider Report for HUMANIGEN, INC

Role
Chief Executive Officer, Director
Signature
/s/ Cameron Durrant
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 17:20:21 UTC
Previous filing
26 Nov 2021
Next filing
14 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $0 +76,000 $0.000000 76,000 31 Dec 2021 Common Stock 76,000 $3.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 12 ratable quarterly installments commencing March 31, 2022.